- Efficacy and safety of anlotinib in advanced leiomyosarcoma🔍
- Retrospective Review of Efficacy and Safety of Anlotinib in ...🔍
- Efficacy and safety of anlotinib in advanced soft tissue sarcoma🔍
- Subgroup analysis of a phase IIB trial 🔍
- Long|Term Efficacy and Safety of Anlotinib as a Monotherapy and ...🔍
- Efficacy and safety of anlotinib hydrochloride in the treatment of ...🔍
- subgroup analysis of a phase IIB trial 🔍
- Anlotinib as a maintenance treatment for advanced soft tissue ...🔍
Efficacy and safety of anlotinib in advanced leiomyosarcoma
Efficacy and safety of anlotinib in advanced leiomyosarcoma
Anlotinib not only improves PFS and DCR significantly, but also presents good safety in patients with LMS, which suggests that anlotinib could be an option for ...
Retrospective Review of Efficacy and Safety of Anlotinib in ... - NCBI
Retrospective study on the safety and efficacy of anlotinib in the treatment of advanced leiomyosarcoma in real-world. Methods. Clinical data ...
Efficacy and safety of anlotinib in advanced leiomyosarcoma
Efficacy and safety of anlotinib in advanced leiomyosarcoma: Subgroup analysis of a phase IIB trial (ALTER0203). Y. Chi1, Y. Yao2, Z. Fang3, S. Wang4, G ...
Efficacy and safety of anlotinib in advanced soft tissue sarcoma
The efficacy and safety of anlotinib is further confirmed in advanced STS patients regarding regional differences.
Subgroup analysis of a phase IIB trial (ALTER0203) - ScienceDirect
Submitted abstracts. Sarcoma. 1693P - Efficacy and safety of anlotinib in advanced leiomyosarcoma: Subgroup analysis of a phase IIB trial (ALTER0203).
Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and ...
Keywords: advanced sarcoma; anlotinib; clinical efficacy; immunotherapy; targeted therapy. © 2022 Yao et al.
(PDF) Retrospective Review of Efficacy and Safety of Anlotinib in ...
PDF | Objective Retrospective study on the safety and efficacy of anlotinib in the treatment of advanced leiomyosarcoma in real-world.
Efficacy and safety of anlotinib hydrochloride in the treatment of ...
Efficacy and safety of anlotinib hydrochloride in the treatment of advanced bone and soft tissue sarcoma after failure of first-line chemotherapy. · Abstract.
subgroup analysis of a phase IIB trial (ALTER0203) | Cochrane Library
Efficacy and safety of anlotinib in advanced leiomyosarcoma: subgroup analysis of a phase IIB trial (ALTER0203). Chi Y, Yao Y, Fang Z, Wang S, Huang G, Cai Q ...
Anlotinib as a maintenance treatment for advanced soft tissue ...
... efficacy and safety of anlotinib ... anlotinib shows significant efficacy and tolerable toxicity in patients with advanced soft tissue sarcoma.
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor ...
Abstract. Purpose: The prognosis for patients with refractory soft-tissue sarcoma (STS) is dismal. Anlotinib has previously shown antitumor activity on.
The efficacy and safety of anlotinib combined with chemotherapy in ...
To evaluate the efficacy and safety of anlotinib combined with chemotherapy in the treatment of advanced soft tissue sarcoma (STS).
[PDF] Retrospective Review of Efficacy and Safety of Anlotinib in ...
It is forecast that anlotinib is effective, safe and alternative in treatment of advanced leiomyosarcoma in real-world, combined with immunotherapy may ...
Efficacy and safety of anlotinib in patients with unresectable or ...
... metastatic bone sarcoma at three institutions. Methods. Patients with advanced bone sarcoma administered anlotinib 12 mg once daily, 2 weeks ...
Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and ...
Therefore, exploring new methods for treating advanced sarcoma is a hot topic and challenging research area. Angiogenesis plays an essential ...
Efficacy and safety of anlotinib combined with liposomal doxorubicin ...
Efficacy and safety of anlotinib combined with liposomal doxorubicin in first-line treatment of advanced soft-tissue sarcoma. · Xin Sun, W. Guo, +2 authors. Jie ...
Poster Display session 1 - ESMO 2019 Congress | OncologyPRO
3157 - Efficacy and safety of anlotinib in advanced leiomyosarcoma: Subgroup analysis of a phase IIB trial (ALTER0203). Date. 28 Sep 2019. Session. Poster ...
Efficacy and safety of anlotinib with and without EGFR-TKIs or ...
Anlotinib is a multitarget tyrosine kinase inhibitor for treating patients with advanced non-small cell lung cancer (NSCLC).
Anlotinib as a maintenance treatment for advanced soft tissue 
sarcoma (STS) after first-line chemotherapy. In this study, we aimed to evaluate the efficacy and safety of anlotinib as a maintenance ...
(PDF) The efficacy and safety of anlotinib combined with ...
PDF | To evaluate the efficacy and safety of anlotinib combined with chemotherapy in the treatment of advanced soft tissue sarcoma (STS).